Search Results

But your GPCR program still isn't moving at the pace it should. The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?

Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based Drug Discovery Conference  isn’t just another event—it’s where the frameworks shaping the next decade GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need Aside from his vast experience in drug development, not to mention his extensive publication record,

GPCR University Masterclass — Integrated GPCR Discovery in Practice Dr. GPCR Masterclass ➤ Eurofins DiscoverX Partnership — Tools and Insight for GPCR Drug Discovery Modern GPCR discovery depends on more than hypotheses. Industry-grade tools signal maturation of GPCR drug discovery. 👉 Read the Partnership Announcement ➤ GPCR Premium Membership Gives You an Edge GPCR drug discovery is accelerating — across obesity, CNS,

Terry Kenakin on detecting, quantifying, and applying receptor signaling bias in GPCR drug discovery. selectivity into a practical decision-making tool in GPCR drug discovery Beyond Potency: What Ligand-Dependent Organizers Eurofins DiscoverX Eurofins DiscoverX is a one-stop-shop for GPCR drug discovery and development GPCR is a membership-based nonprofit ecosystem dedicated to advancing GPCR-targeted drug discovery. Curated intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses

Expert support, trusted CROs, and ready-to-use tools to accelerate GPCR drug discovery, reduce risk, GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence Get Team Access GPCR University Expert-led courses spanning GPCR drug discovery — from receptor biology Book Plan Your Next Move in GPCR Discovery Meet directly with Dr. Let's move your GPCR discovery program forward.

Fiona Marshall on structure-based GPCR drug discovery, the GABA-B heterodimer, the acetate that rewrote Strategic Partner(s) Fiona Marshall: Three Decades Inside GPCR Drug Discovery This conversation traces how structure-based GPCR drug discovery moved from a stubborn crystallography problem to a generative drug discovery actually changed. As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery